|
| Total | CA | RF |
| Number of freeze patients | 1882 | 964 (51.2%) | 918 (48.8%) |
| Age on admission [years] | 64.0 (56 - 7100) | 63.0 (56.0 - 70.0) | 65.0 (57.0 - 71.0) |
| Female | 33.9% | 33.4% | 34.4% |
| Type of AF |
|
|
|
| Paroxysmal AF | 58.9% (1108/1882) | 70.3% (678/964) | 46.8% (430/918) |
| Persistent AF (lasting <1 year) | 41.1% (774/1882) | 29.7% (286/964) | 53.2% (488/918) |
| Cardiac disease | 42.2% | 41.6% | 42.7% |
| Concomitant diseases | 71.7% | 66.9% | 76.8% |
| Hypertension | 63.5% | 59.7% | 67.6% |
| Diabetes | 8.8% | 6.9% | 10.8% |
| Renal failure (GFR < 60) | 4.2% | 3.5% | 4.9% |
| COPD | 3.5% | 2.8% | 4.3% |
| PAD | 1.4% | 1.6% | 1.2% |
| Previous stroke | 2.6% | 2.1% | 3.1% |
| Antithrombotic pretreatment |
|
|
|
| Vitamin-K-antagonist | 27.9% | 19.1% | 37.3% |
| Platelet inhibitors | 3.6% | 4.6% | 2.5% |
| CHA2DS2-vasc score | 2.0 ± 1.4 | 1.8 ± 1.3 | 2.1 ± 1.4 |
| CHA2DS2-vasc score ≥ 2 | 59.0% | 55.1% | 62.5% |
| Cardiac imaging |
|
|
|
| LVEF [%] | 55.0 (55.0 - 60.0) | 60.0 (55.0 - 60.0) | 55.0 (55.0 - 60.0) |
| LA diameter [mm] | 42.0 (39.0 - 47.0) | 42.0 (38.0 - 47.0) | 43.0 (40.0 - 48.0) |